Hepatocyte cell (Cytonet)

N/A

Report date: 2022/06/27 20:00:35

Base Information

Drug NameHepatocyte cell (Cytonet)

Drug Alias NameHHLivCHuman heterologous liver cells for infusionHeparesc

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Hepatocytes therapyCell and gene therapy > Cell therapy > Source of cells > Liver-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsOrnithine Carbamoyltransferase Deficiency DiseaseCitrullinemiaCarbamoyl-Phosphate Synthase I Deficiency Disease +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermanyEU

CombinationsNo

Global Highest StatusDiscontinued (NDA/BLA)

Highest Status in ChinaN/A

Originator CompaniesCytonet

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCytonet Gmbh & Co Kg

Active IndicationsN/A

Inactive IndicationsOrnithine Carbamoyltransferase Deficiency DiseaseCitrullinemiaCarbamoyl-Phosphate Synthase I Deficiency Disease +[4]

Other Information

ATC CodeN/A